Ditchcarbon
  • Customers
  1. Organizations
  2. Gulf Pharmaceutical
Public Profile
Pharmaceutical Preparation Manufacturing
AE
updated 18 days ago

Gulf Pharmaceutical

Company website

Gulf Pharmaceutical Industries, commonly known as Julphar, is a leading pharmaceutical company headquartered in the United Arab Emirates (AE). Established in 1980, Julphar has grown to become a prominent player in the Middle East and North Africa (MENA) region, focusing on the development, manufacturing, and distribution of high-quality pharmaceutical products. With a diverse portfolio that includes prescription medications, over-the-counter products, and biotechnology solutions, Julphar is renowned for its commitment to innovation and quality. The company has achieved significant milestones, including the establishment of state-of-the-art manufacturing facilities and a robust research and development programme. Julphar's dedication to excellence has positioned it as a trusted name in the pharmaceutical industry, contributing to improved healthcare outcomes across its operational regions.

DitchCarbon Score

How does Gulf Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Gulf Pharmaceutical's score of 41 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

65%

Let us know if this data was useful to you

Gulf Pharmaceutical's reported carbon emissions

In 2023, Gulf Pharmaceutical Industries P.S.C. reported total carbon emissions of approximately 137,000 kg CO2e. This figure includes 48,000 kg CO2e from Scope 1 emissions, 38,000 kg CO2e from Scope 2 emissions, and 51,000 kg CO2e from Scope 3 emissions. Notably, the company achieved a 3% reduction in Scope 1 emissions and a 2% reduction in Scope 2 emissions from 2022 to 2023, attributed to decreased diesel and electricity consumption. Gulf Pharmaceutical has set a long-term commitment to achieve net zero emissions by 2050 for both Scope 1 and Scope 2 emissions. This ambitious target reflects the company's dedication to sustainability and aligns with industry standards for climate action. The emissions data is not cascaded from any parent organization, indicating that Gulf Pharmaceutical independently reports its carbon footprint and climate commitments. The company continues to focus on reducing its environmental impact while maintaining operational efficiency.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
6,300,000
0,000,000
00,000
00,000
Scope 2
29,000,000
00,000,000
00,000
00,000
Scope 3
-
-
00,000
00,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Gulf Pharmaceutical's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Gulf Pharmaceutical is in AE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Gulf Pharmaceutical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Rocca & Partners Stichting Administratiekantoor Aandelen San Faustin

NL
Updated 11 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Medseven Drugstore LLC

AE
Updated about 18 hours ago

Jamjoom Pharmaceuticals Factory Company

SA
•
Pharmaceutical Preparation Manufacturing
Updated about 18 hours ago

Aster Dm Healthcare

AE
•
Health and social work services (85)
Updated about 18 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250828.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy